| Entry |
|
|---|
| Name |
Cycloserine;
D-Cycloserine
|
|---|
| Formula |
C3H6N2O2
|
|---|
| Exact mass |
102.0429
|
|---|
| Mol weight |
102.09
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00998 | Biosynthesis of various antibiotics |
| map01110 | Biosynthesis of secondary metabolites |
|
|---|
| Module |
| M00785 | Cycloserine biosynthesis, arginine/serine => cycloserine |
|
|---|
| Enzyme |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AB Antibiotics
J04AB01 Cycloserine
D00877 Cycloserine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antimycobacterials
Antituberculars
Cycloserine
D00877 Cycloserine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
616 Acting mainly on acid-fast bacteria
6162 Cycloserines
D00877 Cycloserine (JP18/USP/INN)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
D00877 Cycloserine
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
D00877 Cycloserine (JP18/USP/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
D00877 Cycloserine (JP17/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00877 Cycloserine
Secondary metabolites in pathway maps [br08011.html]
Biosynthetic pathways and modules of secondary metabolites
C08057
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 7
1 C1x C 24.5033 -16.8772
2 O2x O 25.9039 -16.8772
3 N1x N 26.3366 -15.5452
4 C5x C 25.2036 -14.7219
5 C1y C 24.0705 -15.5452
6 O5x O 25.2036 -13.3057
7 N1a N 22.7503 -15.1162
BOND 7
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 4 6 2
7 5 7 1 #Up
|
|---|
